JAK inhibitors are effective at repigmentation in vitiligo. 5 RCTs, 1,550 pts showed >50% improvement (TVASI50; RR 2.67) or >75% (FVASI75; RR 3.97_ JAKi increased skin AE, but not significantly different from placebo pts. https://t.co/zIreYlUyLt https://t.co/pCWKL2vSVs
Links:
Efficacy and Safety of Janus Kinase Inhibitors in Patients with Vitiligo: A Sys…
https://buff.ly/3PkLDFD
Jan-03-2025
